Latest Options News

HITIQ Limited has extended its Premier League partnership by 18 months with a 60% contract value increase, appointed a new Chief Marketing Officer, and raised an additional $3 million to accelerate global growth.

Tlou Energy advances its Lesedi Gas-to-Power Project with the substation nearing completion and plans to commence power generation later this year, positioning itself to meet Botswana's growing energy needs.

Corazon Mining's December 2024 quarterly report reveals promising exploration progress at its MacBride and Lynn Lake projects in Canada, alongside encouraging drilling results at Mt Gilmore in NSW. A recent capital raise aims to accelerate drilling in early 2025.

Prominence Energy reports steady progress in its uranium and gas exploration projects while pursuing new growth opportunities focused on capital efficiency and operational flexibility.

Riedel Resources has increased its ownership in the Kingman Project to 90%, completed a key cultural survey, and is actively exploring toll treatment options and new projects to expand its portfolio.

American Rare Earths advances its Halleck Creek Project with record high-grade drilling results, a strategic collaboration with BMO Capital Markets, and a significant state grant, reinforcing its role in securing the U.S. rare earth supply chain.

Kingsland Minerals secures a $2.56 million strategic investment from Quinbrook Infrastructure Partners, marking a pivotal step in advancing the Leliyn Graphite Project with binding offtake and renewable energy agreements.

FBR Limited has successfully completed its US Demonstration Program with CRH Ventures, raising $8 million through a Share Purchase Plan and positioning itself for a significant joint venture in the US construction robotics market.

InteliCare advances its AI-driven platform deployment across multiple Hardi Aged Care sites, while expanding its commercial pipeline and enhancing product capabilities.

InteliCare Holdings Limited reported a positive net cash flow of $30,000 for the December quarter, buoyed by a substantial government R&D rebate. The company ends the quarter with $1.26 million in cash, signaling operational stability amid ongoing funding evaluations.

Amplia Therapeutics reports encouraging progress in its Phase 2a ACCENT trial for pancreatic cancer, with nine confirmed partial responses and ongoing patient recruitment. The company also strengthens its financial position with a $13 million capital raise to support further clinical development.

Mineral Commodities Ltd reported a steep net loss of USD 65.1 million for H1 2024, driven by operational disruptions at its Tormin mine and strategic moves including the sale of its Skaland Graphite Project.